{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:50:26Z","timestamp":1775645426750,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":6825,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1111\/j.1600-6143.2004.00382.x","type":"journal-article","created":{"date-parts":[[2004,12,18]],"date-time":"2004-12-18T13:24:12Z","timestamp":1103376252000},"page":"611-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":749,"title":["Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients"],"prefix":"10.1016","volume":"4","author":[{"given":"Carlos","family":"Paya","sequence":"first","affiliation":[]},{"given":"Atul","family":"Humar","sequence":"additional","affiliation":[]},{"given":"Ed","family":"Dominguez","sequence":"additional","affiliation":[]},{"given":"Kenneth","family":"Washburn","sequence":"additional","affiliation":[]},{"given":"Emily","family":"Blumberg","sequence":"additional","affiliation":[]},{"given":"Barbara","family":"Alexander","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Freeman","sequence":"additional","affiliation":[]},{"given":"Nigel","family":"Heaton","sequence":"additional","affiliation":[]},{"given":"Mark D.","family":"Pescovitz","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2004.00382.x_bib1","first-page":"S101","article-title":"The impact of cytomegalovirus infection on graft function and patient outcome","volume":"2","author":"Tolkoff-Rubin","year":"1999","journal-title":"Graft"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1568005310101020179","article-title":"Cytomegalovirus infection in immunocompetent and immunocompromised individuals \u2013 a review","volume":"1","author":"Van\u00e8ikov\u00e1","year":"2001","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib3","first-page":"8","article-title":"Indirect effects of CMV in the solid organ transplant patient","volume":"1","author":"Paya","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib4","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1001\/jama.1989.03420240121038","article-title":"The indirect effects of cytomegalovirus infection on the outcome of organ transplantation","volume":"261","author":"Rubin","year":"1989","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1086\/319225","article-title":"Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients","volume":"32","author":"Singh","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib6","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1517\/13543784.10.9.1745","article-title":"Oral valganciclovir. a new option for the treatment of cytomegalovirus infection and disease in immunocompromised hosts","volume":"10","author":"Reusser","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib7","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib8","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1086\/324516","article-title":"Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir","volume":"184","author":"Razonable","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib9","article-title":"Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation","author":"Couchoud","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib10","first-page":"1357","article-title":"Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection","volume":"60","author":"Winston","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-199856010-00012","article-title":"Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients","volume":"56","author":"Noble","year":"1998","journal-title":"Drugs"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib12","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1097\/00007890-199712150-00022","article-title":"Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors","volume":"64","author":"Seu","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(97)05535-9","article-title":"Randomized trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients","volume":"350","author":"Gane","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib14","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/00007890-199812270-00019","article-title":"A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"66","author":"Flechner","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib15","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1086\/339449","article-title":"Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial","volume":"185","author":"Paya","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib16","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.44.10.2811-2815.2000","article-title":"Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients","volume":"44","author":"Pescovitz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00007890-199810270-00023","article-title":"Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function","volume":"66","author":"Pescovitz","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib18","first-page":"S98","article-title":"Changes in the level of CMV antigenemia (pp65) in liver transplant recipients receiving oral ganciclovir as CMV prophylaxis","volume":"67","author":"Singh","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","article-title":"Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants","volume":"356","author":"Limaye","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa011759","article-title":"A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1067\/mcp.2002.126306","article-title":"Pharmacokinetics of valganciclovir and ganciclovir in renal impariment","volume":"72","author":"Czock","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib22","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1128\/JCM.39.12.4472-4476.2001","article-title":"Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems","volume":"39","author":"Razonable","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib23","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/00007890-200203270-00025","article-title":"The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease","volume":"73","author":"Razonable","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib24","series-title":"nQuery Advisor Release 5 User Guide","first-page":"11-1","year":"2002"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib25","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(97)05535-9","article-title":"Randomised trial of efficacy and safety of oral ganciclovir in prevention of cytomegalovirus disease in liver-transplant recipients","volume":"350","author":"Gane","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib26","unstructured":"Organ Procurement and Transplantation Network. All Kaplan-Meier patient survival rates for transplants performed, 1996\u20132001, and all Kaplan-Meier graft survival rates for transplants performed 24 October 2003, 1996\u20132001. URL http:\/\/www.optn.org."},{"issue":"Suppl. 5","key":"10.1111\/j.1600-6143.2004.00382.x_bib27","first-page":"S431","article-title":"Low frequency of emergence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in solid organ transplant patients receiving valganciclovir or oral ganciclovir prophylaxis","volume":"3","author":"Boivin","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib29","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA-restricted cytomegalovirus (CMV) -specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Li","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib30","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1097\/01.ASN.0000030141.41726.52","article-title":"Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection","volume":"13","author":"Sester","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib31","first-page":"592","article-title":"Overview of patient compliance with medication dosing: a literature review","volume":"6","author":"Greenberg","year":"1984","journal-title":"Clin Ther"},{"key":"10.1111\/j.1600-6143.2004.00382.x_bib32","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the association between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2004.00382.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522074846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522074846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2004.00382.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:29:35Z","timestamp":1761625775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522074846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S1600613522074846"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00382.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00382.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}